Merck (MRK) Non-Current Assets (2016 - 2025)
Historic Non-Current Assets for Merck (MRK) over the last 17 years, with Q3 2025 value amounting to $82.0 billion.
- Merck's Non-Current Assets rose 624.33% to $82.0 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $320.4 billion, marking a year-over-year increase of 661.65%. This contributed to the annual value of $78.3 billion for FY2024, which is 512.3% up from last year.
- Latest data reveals that Merck reported Non-Current Assets of $82.0 billion as of Q3 2025, which was up 624.33% from $80.5 billion recorded in Q2 2025.
- In the past 5 years, Merck's Non-Current Assets registered a high of $82.0 billion during Q3 2025, and its lowest value of $62.0 billion during Q2 2021.
- Moreover, its 5-year median value for Non-Current Assets was $74.5 billion (2023), whereas its average is $74.0 billion.
- The largest annual percentage gain for Merck's Non-Current Assets in the last 5 years was 2088.9% (2022), contrasted with its biggest fall of 263.83% (2022).
- Merck's Non-Current Assets (Quarter) stood at $75.4 billion in 2021, then decreased by 2.64% to $73.4 billion in 2022, then increased by 1.46% to $74.5 billion in 2023, then increased by 5.12% to $78.3 billion in 2024, then rose by 4.68% to $82.0 billion in 2025.
- Its Non-Current Assets stands at $82.0 billion for Q3 2025, versus $80.5 billion for Q2 2025 and $79.6 billion for Q1 2025.